openPR Logo
Press release

Rising Prevalence Of Oncological Disorders Fueling The Growth Of The Market Due To Increasing Cancer Cases And Non-Invasive Diagnosis Methods: Key Factor Driving The Growth In The Virtual Biopsy Market

06-11-2025 02:10 PM CET | Health & Medicine

Press release from: The Business Research Company

Virtual Biopsy

Virtual Biopsy

"Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.

What Is the Expected Virtual Biopsy Market Size During the Forecast Period?
The market size of virtual biopsy has seen swift expansion in the last few years. With an anticipated rise from $0.63 billion in 2024 to $0.71 billion in 2025, the compound annual growth rate (CAGR) stands at 12.2%. The surge during the past years is a result of growing demand for non-intrusive diagnostic techniques, heightened inclination towards early disease identification, increasing proficiency in medical imaging software, a surge in patient convenience and comfort, as well as the increasing accessibility of telemedicine services.

Expectations are high for the virtual biopsy market to experience substantial expansion in the coming years, with projections indicating growth to $1.12 billion in 2029 with a compound annual growth rate (CAGR) of 12.0%. This anticipated growth stretching across the forecast period is linked to an increased concentration on cost-effective healthcare options, a surge in preventative healthcare measures, amplified demand for personalized medication, a rise in requests for minimally invasive cancer therapies, and the escalating importance of precision oncology. Some observed trends for this forecast duration include the evolution of imaging sensors, progressive multimodal biopsy techniques, precision through robotics integration, innovation in non-invasive biomarker detection, and synchronization with three-dimensional (3D) visualization tools.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/customise?id=24424&type=smp

What Are the High-Growth Segments in the Virtual Biopsy Market?
The virtual biopsy market covered in this report is segmented -

1) By Target Thrapeutic Areas: Oncological Disorders, Neurological Disorders, Cardiovascular Disorders, Ophthalmological Disorders, Endocrine Disorders, Gastrointestinal Disorders, Other Target Therapeutic Areas
2) By Cancer Targeted: Solid Malignancies, Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Cancer, Other Cancer Targeteds
3) By Imaging Technologies: Magnetic Resonance Imaging, Computed Tomography, X-Ray, Ultrasound, Other Imaging Technologies
4) By End Users: Hospitals And Clinics, Research Institutes And Diagnostic Centers, Other End Users

Subsegments:
1) By Oncological Disorders: Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Liver Cancer, Brain Tumors, Other Cancers
2) By Neurological Disorders: Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Epilepsy, Brain Injuries, Stroke, Other Neurological Conditions
3) By Cardiovascular Disorders: Coronary Artery Disease, Heart Failure, Arrhythmias, Aortic Aneurysm, Valvular Heart Disease, Myocardial Infarction, Other Cardiovascular Conditions
4) By Ophthalmological Disorders: Age-Related Macular Degeneration, Diabetic Retinopathy, Glaucoma, Retinal Vein Occlusion, Cataracts, Other Eye Disorders
5) By Endocrine Disorders: Diabetes Mellitus, Thyroid Disorders, Adrenal Gland Disorders, Pituitary Gland Disorders, Parathyroid Disorders, Other Endocrine Conditions
6) By Gastrointestinal Disorders: Inflammatory Bowel Disease, Colorectal Polyps, Gastric Ulcers, Liver Cirrhosis, Pancreatic Disorders, Hepatitis, Other Gastrointestinal Conditions
7) By Other Target Therapeutic Areas: Musculoskeletal Disorders, Renal Disorders, Pulmonary Disorders, Hematologic Disorders, Dermatological Disorders, Infectious Diseases, Other Miscellaneous Conditions

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24424&type=smp

What Key Drivers Are Expected to Influence Future Virtual Biopsy Market Growth?
The escalating incidence of cancer-related diseases is anticipated to boost the expansion of the virtual biopsy market. Cancer-related diseases refer to health problems caused by the abnormal growth and spread of cells in the body. The alarming increase in these disorders primarily stems from lifestyle alterations such as inadequate diet, lack of physical activity, tobacco consumption, and escalating exposure to environmental pollutants. Virtual biopsy enhances the diagnosis and supervision of these disorders by providing non-invasive, instant imaging perceptions, reducing the requirement for conventional tissue biopsies and improving precision and patient safety. For example, as per the Australian Institute of Health and Welfare, a government agency based in Australia, there was a rise in the number of cancer cases diagnosed in Australia, reaching 160,570 in 2022, an increment of 3,789 cases compared to 156,781 in 2021. Hence, the surging incidence of cancer-related diseases is influencing the expansion of the virtual biopsy market.

Which Companies Hold the Largest Share Across Different Virtual Biopsy Market Segments?
Major companies operating in the virtual biopsy market are Canon Inc., Siemens Healthineers AG, GE Healthcare, Quest Diagnostics Incorporated, Olympus Corporation, Hologic Inc., Illumina Inc., Guardant Health Inc., Esaote S.p.A, Samsung Medison Co Ltd., Telix Pharmaceuticals Limited, Freenome Holdings Inc., Perspectum Ltd., QUIBIM S.L, IQ-AI Limited, BrainSpec Inc., Oncoustics Inc, ImageBiopsy Lab GmbH, AI Metrics LLC, Deep Bio Inc.

What Are the Major Trends Shaping the Virtual Biopsy Market?
Leading businesses in the virtual biopsy market are dedicated to inventing sophisticated technological solutions and obtaining certifications. This includes platforms such as Magnetic Resonance Spectroscopy (MRS) which improve non-invasive diagnostic precision and offer real-time assessments for early disease identification and individualized care. MRS is a non-invasive imaging procedure that aids virtual biopsies by providing intricate molecular tissue information. This enables precise, real-time disease identification and tracking without the requirement for invasive methods. For example, in November 2023, BrainSpec Inc., a US-based health technology firm, obtained U.S. Food and Drug Administration (FDA) approval for their AI-driven BrainSpec platform. This technology utilizes advanced AI to analyze MR spectroscopy data to determine brain metabolites such as 2-hydroxyglutarate, aiding non-invasive virtual biopsies in diagnosing ailments such as gliomas, Alzheimer's and multiple sclerosis. The system effortlessly integrates with standard Magnetic Resonance Imaging (MRI) scanners, simplifies data processing, delivering results in minutes. This system also leverages a reference database of brain chemistry to enhance diagnostic precision.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/virtual-biopsy-global-market-report

What Are the Emerging Geographies for The Virtual Biopsy Market Growth?
North America was the largest region in the virtual biopsy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the virtual biopsy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Virtual Biopsy Market?
2. What is the CAGR expected in the Virtual Biopsy Market?
3. What Are the Key Innovations Transforming the Virtual Biopsy Industry?
4. Which Region Is Leading the Virtual Biopsy Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company provides in-depth research and insights through a vast collection of 15,000+ reports spanning 27 industries and over 60 geographies. Backed by 1,500,000 datasets, extensive secondary research, and expert insights from industry leaders, we equip you with the knowledge needed to stay ahead in the market.

Our flagship offering, the Global Market Model, is a leading market intelligence platform that delivers comprehensive and up-to-date forecasts to support strategic decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Rising Prevalence Of Oncological Disorders Fueling The Growth Of The Market Due To Increasing Cancer Cases And Non-Invasive Diagnosis Methods: Key Factor Driving The Growth In The Virtual Biopsy Market here

News-ID: 4061775 • Views:

More Releases from The Business Research Company

Seed Treatment Fungicides Market to Grow at 9.3% CAGR, Reaching $3.15 Billion by 2029
Seed Treatment Fungicides Market to Grow at 9.3% CAGR, Reaching $3.15 Billion by …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide. Seed Treatment Fungicides Market Outlook: How is the Market Expected to Grow by 2025? Over the past few years, the market for seed treatment fungicides has seen robust growth. Its market value is projected to rise from $2.07 billion in 2024 to $2.21 billion in 2025, signifying a compound annual
Rheology Modifiers Market Growth to be Driven by Emerging Trends | $10.92 Billion by 2029
Rheology Modifiers Market Growth to be Driven by Emerging Trends | $10.92 Billio …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports. What is the Projected Market Size of the Rheology Modifiers Industry? There has been a consistent expansion in the size of the rheology modifiers market in the past few years. The market, which was worth $8.59 billion in 2024, is projected to increase to $8.89 billion in 2025, demonstrating a compound
Polyurethane Foam Market to Record 8.4% CAGR Growth Through 2029 | Global Analysis Report
Polyurethane Foam Market to Record 8.4% CAGR Growth Through 2029 | Global Analys …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide. Polyurethane Foam Market Outlook: How is the Market Expected to Grow by 2025? In recent years, the size of the polyurethane foam market has experienced substantial growth. It is projected to increase from a value of $54.27 billion in 2024 to $57.26 billion in 2025, indicating a compound annual growth
Pharmaceutical Intermediates Market Size to Reach $46.04 Billion by 2029 | Growth at 7.1% CAGR Forecast
Pharmaceutical Intermediates Market Size to Reach $46.04 Billion by 2029 | Growt …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports. What is the Projected Market Size of the Pharmaceutical Intermediates Industry? There has been consistent growth in the market size of pharmaceutical intermediates over the past few years. The market is predicted to increase from a value of $33.37 billion in 2024, up to $34.95 billion in 2025, with a compound

All 5 Releases


More Releases for Disorders

Bleeding Disorders Market Is Driven By Bleeding Disorders In Various Industries, …
The Bleeding Disorders Market is a critical component of the healthcare industry, focused on the diagnosis, treatment, and management of bleeding disorders that affect individuals' blood clotting mechanisms. These disorders, which include hemophilia, von Willebrand disease, and various clotting factor deficiencies, can lead to prolonged and spontaneous bleeding, posing significant health risks. This market encompasses a range of therapies, medications, and diagnostic tools designed to address the unique needs of
Gene Therapy For Rare Disease Market By Therapeutic Application ( Oncology, Neur …
The Gene Therapy For Rare Disease Market report outlines the evolution of Gene Therapy For Rare Disease industry by type, applications and identifies and assesses the best performing vendors in the market till 2028. Gene Therapy For Rare Disease Market reports present the revenue opportunities in the Gene Therapy For Rare Disease industry through 2023-2028, highlighting the market size and growth by technology, geography, vertical and End users. Download Sample PDF
Neuroprosthetics Market 2019 Industry Segmentation by physiological disorders ar …
Neuroprosthetics Market 2019 Scenario Neuroprosthetics Market was estimated to be USD 5.28 billion in 2016 and expected to reach USD 10.48 billion by 2023. The key factors responsible for driving this are increasing in geriatric population, auditory processing disorders in kids, and increase in spinal cord treatment due to advancement in neuroprosthetics devices. The factors responsible for the positive growth of this market are increasing prevalence of neural diseases, over active bladder
11-29-2018 | Health & Medicine
Fact.MR
Global Vocal Biomarker Market to Experience Significant Growth during the Foreca …
Vocal patterns have been used by clinical psychologists and psychoanalysts for analyzing personality traits of patients, and helping creation of headway in clinical and medical investigations. Recent breakthroughs in the healthcare sector have led to the development of a unique diagnostic tool known as Vocal Biomarker Market by combining the concept of biological markers with the aforementioned methodology to analyze personality traits. Claim Sample Report For FREE: https://www.factmr.com/connectus/sample?flag=S&rep_id=719 These vocal biomarkers are
Behavioral Therapy Market Report 2018: Segmentation by Type (Anxiety Disorders, …
Global Behavioral Therapy market research report provides company profile for American Addiction Centers, ChanceLight, Haven Behavioral Healthcare, Behavioral Health Group, Center for Autism & Related Disorders, People’s Care, Magellan Health, Universal Health Services, Acadia Healthcare, Springstone and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY
Biopharmaceuticals Market Outlook 2025|( Biopharmaceuticals Application:- Infect …
Global Biopharmaceuticals Market Research Report Brief Focus On Study About Biopharmaceuticals Market Industry volume, Market Revenue, Market Segments , Market Trends ,Growth aspects A wide range of applications, Utilization ratio, Supply and demand analysis are also consist in the report such as: Biopharmaceuticals Product Type:- Monoclonal Antibodies, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Synthetic Immunomodulators, Vaccines, Biopharmaceuticals Application :- Inflammatory , Infectious Diseases, Autoimmune Disorders, Metabolic